Teva Pharmaceutical Industries Ltd (TEVA)

9.64 -0.16  -1.63% NYSE Dec 13, 20:00 Delayed 2m USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
02/13/2020 08:00 EST Misc Teva Pharmaceutical Industries Ltd Fourth Quarter Earnings Conference Call in 2019
02/13/2020 Earnings Teva Pharmaceutical Industries Ltd Fourth Quarter Earnings in 2019 Release
11/07/2019 08:00 EST Misc Teva Pharmaceutical Industries Ltd Third Quarter Earnings Conference Call for 2019
11/07/2019 Earnings Teva Pharmaceutical Industries Ltd Third Quarter Earnings for 2019 Release
08/07/2019 08:00 EDT Misc Teva Pharmaceutical Industries Ltd Second Quarter Earnings Conference Call in 2019
08/07/2019 Earnings Teva Pharmaceutical Industries Ltd Second Quarter Earnings in 2019 Release
06/11/2019 Misc Teva Pharmaceutical Industries Ltd Annual General Meeting in 2018
05/02/2019 08:00 EDT Misc Teva Pharmaceutical Industries Ltd First Quarter Earnings Conference Call in 2019
05/02/2019 Earnings Teva Pharmaceutical Industries Ltd First Quarter Earnings in 2019 Release
02/19/2019 Misc Teva Pharmaceutical Industries Ltd Annual Report in 2018
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: http://www.tevapharm.com
  • Investor Relations URL: http://ir.tevapharm.com/phoenix.zhtml?c=73925&p=irol-irhome
  • HQ State/Province: N/A
  • Sector: Healthcare
  • Industry: Drug Manufacturers - Specialty & Generic
  • Equity Style: Mid Cap/Value
  • Next Earnings Release: Feb. 13, 2020
  • Last Earnings Release: Nov. 07, 2019
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: Nov. 27, 2017
  • Description: Teva Pharmaceutical Industries Ltd is the largest generic drug manufacturer in the world with more than 60 manufacturing and R&D facilities, headquartered in Israel. The company was formed in 1901 and has a portfolio of more than 3,500 medicines--roughly one out of nine generic prescriptions in the U.S. is filled with a Teva product. The company also develops branded pharmaceuticals in the central nervous system, oncology, and respiratory categories. Teva's generic drug sales represent about half of total revenue, with branded drug and distribution revenue making up the balance. Teva is an aggressive filer to bring generic drugs to market when brand patents expire and has the most generic products pending FDA approval.

Top Fund Holders

Symbol Name Weighting
EIS iShares MSCI Israel Capped ETF 7.98%
UPUPX Upright Growth 4.30%
PPH VanEck Vectors Pharmaceutical ETF 4.09%
BMPEX Beck, Mack & Oliver Partners 2.49%
IZRL ARK Israel Innovative Technology ETF 2.27%
DROCX Diamond Hill Research Opportunities C 2.20%
CCM2630 IA Clarington Global Opportunities I 1.90%
TAM003 Thornmark Dividend & Income 1.83%
SBIDX Sterling Capital Behavioral Intl Eq C 1.31%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.